A detailed history of Mariner, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Mariner, LLC holds 40,751 shares of DRTS stock, worth $93,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,751
Previous 41,894 2.73%
Holding current value
$93,727
Previous $105,000 8.57%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.01 - $2.55 $2,297 - $2,914
-1,143 Reduced 2.73%
40,751 $96,000
Q2 2024

Aug 13, 2024

BUY
$2.05 - $2.9 $6,785 - $9,599
3,310 Added 8.58%
41,894 $105,000
Q4 2023

Feb 14, 2024

BUY
$2.75 - $3.89 $106,106 - $150,091
38,584 New
38,584 $116,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $159M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.